Skip to main content

Smart-C - A phase IIIb open-label, multicentre, international randomised controlled trial of simplified treatment monitoring for 8 weeks glecapevir (300 gm)/pibrentasvis (120mg) in chronic HCV treatment naive patients without cirrhosis.

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Gastroenterology

Awarded By

The Kirby Institute

Start Date

February 5, 2018

End Date

December 31, 2019
 

Administered By

Medicine, Gastroenterology

Awarded By

The Kirby Institute

Start Date

February 5, 2018

End Date

December 31, 2019